25538727|t|The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using (18)F-AV45: Is Amyloid the Principal Actor in the Disease?
25538727|a|BACKGROUND: Posterior cortical atrophy (PCA) is characterized by progressive higher-order visuoperceptual dysfunction and praxis declines. This syndrome is related to a number of underlying diseases, including, in most cases, Alzheimer's disease (AD). The aim of this study was to compare the amyloid load with (18)F-AV45 positron emission tomography (PET) between PCA and AD subjects. METHODS: We performed (18)F-AV45 PET, cerebrospinal fluid (CSF) biomarker analysis and a neuropsychological assessment in 11 PCA patients and 12 AD patients. RESULTS: The global and regional (18)F-AV45 uptake was similar in the PCA and AD groups. No significant correlation was observed between global (18)F-AV45 uptake and CSF biomarkers or between regional (18)F-AV45 uptake and cognitive and affective symptoms. CONCLUSION: This (18)F-AV45 PET amyloid imaging study showed no specific regional pattern of cortical (18)F-AV45 binding in PCA patients. These results confirm that a distinct clinical phenotype in amnestic AD and PCA is not related to amyloid distribution.
25538727	37	63	Posterior Cortical Atrophy	Disease	MESH:D001284
25538727	70	80	(18)F-AV45	Chemical	MESH:C545186
25538727	141	167	Posterior cortical atrophy	Disease	MESH:D001284
25538727	169	172	PCA	Disease	MESH:D001284
25538727	219	246	visuoperceptual dysfunction	Disease	MESH:D006331
25538727	355	374	Alzheimer's disease	Disease	MESH:D000544
25538727	376	378	AD	Disease	MESH:D000544
25538727	422	429	amyloid	Disease	MESH:C000718787
25538727	440	450	(18)F-AV45	Chemical	MESH:C545186
25538727	494	497	PCA	Disease	MESH:D001284
25538727	502	504	AD	Disease	MESH:D000544
25538727	537	547	(18)F-AV45	Chemical	MESH:C545186
25538727	640	643	PCA	Disease	MESH:D001284
25538727	644	652	patients	Species	9606
25538727	660	662	AD	Disease	MESH:D000544
25538727	663	671	patients	Species	9606
25538727	706	716	(18)F-AV45	Chemical	MESH:C545186
25538727	743	746	PCA	Disease	MESH:D001284
25538727	751	753	AD	Disease	MESH:D000544
25538727	817	827	(18)F-AV45	Chemical	MESH:C545186
25538727	874	884	(18)F-AV45	Chemical	MESH:C545186
25538727	896	928	cognitive and affective symptoms	Disease	MESH:D019954
25538727	947	957	(18)F-AV45	Chemical	MESH:C545186
25538727	962	969	amyloid	Disease	MESH:C000718787
25538727	1032	1042	(18)F-AV45	Chemical	MESH:C545186
25538727	1054	1057	PCA	Disease	MESH:D001284
25538727	1058	1066	patients	Species	9606
25538727	1137	1139	AD	Disease	MESH:D000544
25538727	1144	1147	PCA	Disease	MESH:D001284
25538727	1166	1173	amyloid	Disease	MESH:C000718787
25538727	Negative_Correlation	MESH:C545186	MESH:C000718787
25538727	Association	MESH:C545186	MESH:D019954

